Laboratório de Fitotecnologia, Departamento de Farmácia, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, 35400-000, Brazil.
Nano Lab, Departamento de Engenharia Metalúrgica e de Materiais, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, 35400-000, Brazil.
Nanomedicine (Lond). 2024;19(14):1285-1296. doi: 10.1080/17435889.2024.2345044. Epub 2024 May 9.
To investigate whether medical devices coated with a synthesized nanocomposite of poly(methylmethacrylate-co-dimethyl acrylamide) (PMMDMA) and silver nanoparticles (AgNPs) could improve their antibiofilm and antimicrobial activities. We also investigated the nanocomposite's safety. The nanocomposite was synthesized and characterized using analytical techniques. Medical devices coated with the nanocomposite were evaluated for bacterial adhesion and hemolytic activity . The nanocomposite formation was demonstrated with the incorporation of AgNPs into the polymer matrix. The nanocomposite proved to be nonhemolytic and significantly inhibited bacterial biofilm formation. The PMMDMA-AgNPs nanocomposite was more effective in preventing biofilm formation than PMMDMA alone and is a promising strategy for coating medical devices and reducing mortality due to hospital-acquired infections.
为了研究是否可以通过在医疗器械表面涂覆聚甲基丙烯酸甲酯-共-二甲基丙烯酰胺(PMMDMA)和银纳米粒子(AgNPs)的合成纳米复合材料来提高其抗生物膜和抗菌活性。我们还研究了纳米复合材料的安全性。采用分析技术合成和表征了纳米复合材料。评估了涂覆纳米复合材料的医疗器械的细菌黏附和溶血活性。通过将 AgNPs 掺入聚合物基质中证明了纳米复合材料的形成。纳米复合材料被证明是非溶血的,并且可以显著抑制细菌生物膜的形成。与单独的 PMMDMA 相比,PMMDMA-AgNPs 纳米复合材料在预防生物膜形成方面更有效,是一种有前途的涂覆医疗器械的策略,可以降低因医院获得性感染导致的死亡率。